<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2984705R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2786</journal-id>
<journal-id journal-id-type="nlm-ta">Cancer Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Cancer Res.</journal-id>
<journal-title-group>
<journal-title>Cancer research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0008-5472</issn>
<issn pub-type="epub">1538-7445</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31575548</article-id>
<article-id pub-id-type="pmc">7153784</article-id>
<article-id pub-id-type="doi">10.1158/0008-5472.CAN-19-1169</article-id>
<article-id pub-id-type="manuscript">NIHMS1540615</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Libby</surname>
<given-names>Catherine J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McConathy</surname>
<given-names>Jonathan</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Darley-Usmar</surname>
<given-names>Victor</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hjelmeland</surname>
<given-names>Anita B.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA</aff>
<aff id="A2"><label>2</label>Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA</aff>
<aff id="A3"><label>3</label>Mitochondrial Medicine Laboratory, Center for Free Radical Biology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA</aff>
<author-notes>
<corresp id="CR1">Correspondence: Anita B. Hjelmeland, Ph.D., Associate Professor, Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, <email>hjelmea@uab.edu</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P30">Potential Conflicts of Interest: The authors declare no conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>11</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>7</month>
<year>2020</year>
</pub-date>
<volume>80</volume>
<issue>1</issue>
<fpage>5</fpage>
<lpage>16</lpage>
<!--elocation-id from pubmed: 10.1158/0008-5472.CAN-19-1169-->
<abstract id="ABS1">
<p id="P1">Our understanding of intratumoral heterogeneity in cancer continues to evolve, with current models incorporating single cell signatures to explore cell-cell interactions and differentiation state. The transition between stem and differentiation states in non-neoplastic cells requires metabolic plasticity, and this plasticity is increasingly recognized to play a central role in cancer biology. The insights from hematopoietic and neural stem cell differentiation pathways were used to identify cancer stem cells in leukemia and gliomas. Similarly, defining metabolic heterogeneity and fuel switching signals in non-neoplastic stem cells may also give important insights into the corresponding molecular mechanisms controlling metabolic plasticity in cancer. These advances are important, because metabolic adaptation to anti-cancer therapeutics is rooted in this inherent metabolic plasticity and is a therapeutic challenge to be overcome.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>